REGENERON PHARMACEUTICALS INC

REGENERON PHARMACEUTICALS INC has $288,212,197 in federal contract obligations across 2 award records in the ingested USAspending contract dataset. Figures are derived from procurement award type codes A, B, C, and D only.

Quick answer

REGENERON PHARMACEUTICALS INC has $288,212,197 in ingested federal contract obligations across 2 award records in this contractor profile.

Contractor Snapshot

Total obligations$288,212,197
Award records2
Entity codeN3F9MH7E6HD6
Data updatedMay 7, 2026
Top relationshipDepartment of Health and Human Services
Top category541711 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY

Source: USAspending.gov. Last updated from ingested federal spending data: May 7, 2026.

Market Analysis

REGENERON PHARMACEUTICALS INC has $288,212,197 across 2 ingested award records, with the analysis below generated only from visible tables on this page.

Concentration

Department of Health and Human Services accounts for 100.0% of REGENERON PHARMACEUTICALS INC's visible obligations in this slice, which is the first concentration signal to review before treating the market as broad or fragmented.

  • Top relationship: Department of Health and Human Services
  • Top value: $288,212,197

Buyer And Category Mix

541711 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY is the largest visible secondary category at $288,212,197. Use this alongside the relationship table to separate one-off award activity from repeat market exposure.

  • Largest secondary category: 541711 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY
  • Category value: $288,212,197

Recent Award Signal

The latest displayed award is HHSO100201700020C from FY2021 with $279,610,568 in obligations. Recent rows help identify whether the profile is still active in current procurement data.

  • Award date: Not listed
Source caveats
  • USAspending records can be revised after initial publication.
  • Negative obligations and deobligations may affect totals in narrow slices.

Spending by Fiscal Year

FY20212 awards$288,212,197

Top Agencies

Department of Health and Human Services2 awards$288,212,197

Top NAICS Codes

541711 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY2 awards$288,212,197

Recent Awards

AwardRecipientFiscal yearObligationsDate
HHSO100201700020CREGENERON PHARMACEUTICALS INC2021$279,610,568Not available
HHSO100201600023CREGENERON PHARMACEUTICALS INC2021$8,601,629Not available
Citation facts

REGENERON PHARMACEUTICALS INC has $288,212,197 in ingested federal contract obligations across 2 award records in this contractor profile.

Source
USAspending.gov procurement award records
Data updated
May 7, 2026
Canonical URL
https://www.govspending.us/contractor/regeneron-pharmaceuticals-inc-n3f9mh7e6hd6

Federal Contract Questions

How much federal contract spending is associated with REGENERON PHARMACEUTICALS INC?

REGENERON PHARMACEUTICALS INC has $288,212,197 in ingested contract obligations across 2 award records.

Which relationships matter most for REGENERON PHARMACEUTICALS INC?

Department of Health and Human Services is the largest listed relationship in this profile at $288,212,197.

Which industries or buyers are most visible?

541711 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY is the largest listed secondary category at $288,212,197.

Source: USAspending.gov. Last updated from ingested federal spending data: May 7, 2026.

Methodology